Growth Metrics

Vertex Pharmaceuticals (VRTX) Cost of Revenue (2016 - 2026)

Quarterly Cost of Revenue rose 8.21% to $392.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.7 billion through Mar 2026, up 8.4% year-over-year, with the annual reading at $1.7 billion for FY2025, 7.89% up from the prior year.

Vertex Pharmaceuticals' Cost of Revenue history spans 16 years, with the latest figure at $392.8 million for Q1 2026.

  • Cost of Revenue came in at $392.8 million for Q1 2026, down from $466.0 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $466.0 million in Q4 2025 to a low of $245.8 million in Q1 2022.
  • The 5-year median for Cost of Revenue is $363.0 million (2025), against an average of $348.1 million.
  • Year-over-year, Cost of Revenue grew 29.9% in 2023 and then grew 5.65% in 2025.
  • Vertex Pharmaceuticals' Cost of Revenue stood at $283.3 million in 2022, then increased by 29.9% to $368.0 million in 2023, then rose by 15.05% to $423.4 million in 2024, then rose by 10.06% to $466.0 million in 2025, then dropped by 15.71% to $392.8 million in 2026.
  • Per Business Quant, the three most recent readings for VRTX's Cost of Revenue are $392.8 million (Q1 2026), $466.0 million (Q4 2025), and $414.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 64.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 392.80 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 296.00 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 207.52 Mn
10 Revolution Medicines 30.42 Bn 30.42 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 392.80 Mn
Mar 31, 2026 392.80 Mn
Dec 31, 2025 466.00 Mn
Dec 31, 2025 466.00 Mn
Sep 30, 2025 414.80 Mn
Sep 30, 2025 414.80 Mn
Jun 30, 2025 407.50 Mn
Jun 30, 2025 407.50 Mn
Mar 31, 2025 363.00 Mn
Mar 31, 2025 363.00 Mn
Dec 31, 2024 423.40 Mn
Dec 31, 2024 423.40 Mn
Sep 30, 2024 392.60 Mn
Sep 30, 2024 392.60 Mn
Jun 30, 2024 371.90 Mn
Jun 30, 2024 371.90 Mn
Mar 31, 2024 342.60 Mn
Mar 31, 2024 342.60 Mn
Dec 31, 2023 368.00 Mn
Dec 31, 2023 368.00 Mn
Sep 30, 2023 318.70 Mn
Sep 30, 2023 318.70 Mn
Jun 30, 2023 308.60 Mn
Jun 30, 2023 308.60 Mn
Mar 31, 2023 266.90 Mn
Mar 31, 2023 266.90 Mn
Dec 31, 2022 283.30 Mn
Dec 31, 2022 283.30 Mn
Sep 30, 2022 289.40 Mn
Sep 30, 2022 289.40 Mn
Jun 30, 2022 261.80 Mn
Jun 30, 2022 261.80 Mn
Mar 31, 2022 245.80 Mn
Mar 31, 2022 245.80 Mn
Dec 31, 2021 247.40 Mn
Dec 31, 2021 247.40 Mn
Sep 30, 2021 236.50 Mn
Sep 30, 2021 236.50 Mn
Jun 30, 2021 228.00 Mn
Jun 30, 2021 228.00 Mn
Mar 31, 2021 192.30 Mn
Mar 31, 2021 192.30 Mn
Dec 31, 2020 203.10 Mn
Dec 31, 2020 203.10 Mn
Sep 30, 2020 186.18 Mn
Sep 30, 2020 186.18 Mn
Jun 30, 2020 184.52 Mn
Jun 30, 2020 184.52 Mn
Mar 31, 2020 162.50 Mn
Mar 31, 2020 162.50 Mn
Dec 31, 2019 185.01 Mn
Dec 31, 2019 185.01 Mn
Sep 30, 2019 131.91 Mn
Sep 30, 2019 131.91 Mn
Jun 30, 2019 135.74 Mn
Jun 30, 2019 135.74 Mn
Mar 31, 2019 95.09 Mn
Mar 31, 2019 95.09 Mn
Dec 31, 2018 122.29 Mn
Dec 31, 2018 122.29 Mn
Sep 30, 2018 111.26 Mn
Sep 30, 2018 111.26 Mn
Jun 30, 2018 104.38 Mn
Jun 30, 2018 104.38 Mn
Mar 31, 2018 71.61 Mn
Mar 31, 2018 71.61 Mn
Dec 31, 2017 84.05 Mn
Dec 31, 2017 84.05 Mn
Sep 30, 2017 72.87 Mn
Sep 30, 2017 72.87 Mn
Jun 30, 2017 71.21 Mn
Jun 30, 2017 71.21 Mn
Mar 31, 2017 46.99 Mn
Mar 31, 2017 46.99 Mn
Dec 31, 2016 59.65 Mn
Dec 31, 2016 59.65 Mn
Sep 30, 2016 53.22 Mn
Sep 30, 2016 53.22 Mn
Jun 30, 2016 44.15 Mn
Jun 30, 2016 44.15 Mn